Amneal Pharmaceuticals, Inc. AMRX Specialty — Cost of goods sold

Other segment segments

Similar metrics at other companies

LKQSpecialty — Cost of goods sold

$310M+3.7%

BCPCSpecialty Products — Cost of Sales

$14.26M-10.8%

PRMSpecialty Products — Adjusted cost of goods sold

$45.29M+100%

PFG

PFGCSpecialty — Cost of Goods Sold

$984M+5.8%

GTLSSpecialty Products — Cost of Sales

$168.8M-12.3%

RPMSpecialty Products Group — Cost of Goods Sold

$109.62M-2.7%

Questions, answered.

What is Amneal Pharmaceuticals, Inc.'s specialty — cost of goods sold?

Amneal Pharmaceuticals, Inc. (AMRX) reported specialty — cost of goods sold of $43.02M in Q1 2026.

How has Amneal Pharmaceuticals, Inc.'s specialty — cost of goods sold changed year-over-year?

Amneal Pharmaceuticals, Inc.'s specialty — cost of goods sold decreased by 19.0% year-over-year, from $53.08M to $43.02M.

What does specialty — cost of goods sold mean?

Includes all direct costs attributable to the production and manufacturing of specialty pharmaceutical products, such as raw materials, labor, and overhead. Monitoring this metric helps evaluate manufacturing efficiency and the direct cost burden of the segment's product portfolio.